Magnesium Sulphate for Attenuation of Hemodynamic Pressor Response After Myfield's Clamp Application

Sponsor
El-Sahel Teaching Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03318471
Collaborator
(none)
60
2
20

Study Details

Study Description

Brief Summary

Use of Mayfield skull clamp during craniotomies; results in a sharp and intense noxious stimulus which results in a severe hemodynamic pressor response. Many strategies have been reported to blunt this undesirable pressor effect. This prospective, double blind, and randomized study is the first to evaluate the effect of MgSo4 on attenuation of hemodynamic pressor activity after head clamp application during craniotomies.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Background: Use of Mayfield skull clamp during craniotomies; results in a sharp and intense noxious stimulus which results in a severe hemodynamic pressor response. Many strategies have been reported to blunt this undesirable pressor effect. This prospective, double blind, and randomized study is the first to evaluate the effect of MgSo4 on attenuation of hemodynamic pressor activity after head clamp application during craniotomies.

Methods: This randomized, double blind, and prospective study was done in Neurosurgical department at ElSahel Teaching Hospital in Cairo from February 2016 till august 2017. All adult patients aged from 18 to 60 years of both genders, ASA physical status I and II scheduled for craniotomies were assessed to enter this study. Seventy one patients were assessed preoperatively, sixty of them were enrolled and assigned in two groups (n=30 each). Group M received 50 mg/kg MgSo4 in 100 ml 0.9 sodium Chloride 15 minutes prior to anesthesia induction over 15 minutes. Group S received 100ml 0.9% Sodium Chloride over the same period with the same rate.Mean HR was recorded as a primary outcome , meanwhile; MAP and the need for a bolus dose of fentanyl was considered a secondary outcome.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Intravenous Single Dose of Magnesium Sulphate on Attenuation of Hemodynamic Pressor Response After Myfield's Clamp Application During Craniotomies
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
Oct 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group M

received 50 mg/kg MgSo4 in 100 ml 0.9 NaCl 15 minutes prior to anesthesia induction over 15 minutes

Drug: MgSo4
50 mg/kg MgSo4 in 100 ml 0.9 sodium Chloride 15 minutes prior to anesthesia induction over 15 minutes
Other Names:
  • magnesium sulphate
  • Placebo Comparator: Group S

    received 100 ml 0.9% NaCl 15 minutes prior to anesthesia induction over 15 minutes.

    Drug: 0.9% NaCl
    100 ml 0.9% NaCl 15 minutes prior to anesthesia induction over 15 minutes
    Other Names:
  • normal saline
  • Outcome Measures

    Primary Outcome Measures

    1. Mean HR [From time of insertion over 30 minutes period {at the time of pins insertion (Pin 0),60 seconds ( pin 60'), 5 minutes (pin 5''), 10 minutes ( pin 10''), 20 minutes ( pin 20'') and 30 minutes (pin 30'').}]

      Mean heart rate/min.

    Secondary Outcome Measures

    1. MAP [From time of insertion over 30 minutes period {at the time of pins insertion (Pin 0),60 seconds ( pin 60'), 5 minutes (pin 5''), 10 minutes ( pin 10''), 20 minutes ( pin 20'') and 30 minutes (pin 30'').}]

      Mean arterial Blood Pressure (mmHg)

    2. Need for a bolus opioid [from time of insertion over 30 minutes .]

      Need for a bolus fentanyl after pins insertion to alleviate pressor effects

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All adult patients aged from 18 to 60 years

    • of both genders

    • ASA physical status I and II

    • scheduled for craniotomies

    Exclusion Criteria:
    • history of MgSo4 consumption or allergy

    • renal disease

    • hepatic or endocrine disorder

    • cardiovascular dysfunction

    • calcium channel blocker intake

    • drug abuse were excluded from this study.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • El-Sahel Teaching Hospital

    Investigators

    • Principal Investigator: Samir A ElKafrawy, MD, ElSahel Teaching hospital,Cairo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Samir Ahmed Ahmed ElKafrawy, Fellow of Anesthesia & Pain Relief, El-Sahel Teaching Hospital
    ClinicalTrials.gov Identifier:
    NCT03318471
    Other Study ID Numbers:
    • 2017101
    First Posted:
    Oct 24, 2017
    Last Update Posted:
    Oct 24, 2017
    Last Verified:
    Oct 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samir Ahmed Ahmed ElKafrawy, Fellow of Anesthesia & Pain Relief, El-Sahel Teaching Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 24, 2017